tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kyle Bauser, 61 are a BUY (92.42%), 5 are a HOLD (7.58%).
Analyst Kyle Bauser, currently employed at ROTH MKM, carries an average stock price target met ratio of 43.82% that have a potential upside of 40.37% achieved within 215 days. Previously, Kyle Bauser worked at BTIG, CANACCORD, COLLIERS, LAKE STREET, B. RILEY.
Kyle Bauser’s has documented 127 price targets and ratings displayed on 24 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on OBIO, Orchestra BioMed Holdings at 19-May-2026.
Analyst best performing recommendations are on CEMI (CHEMBIO DIAGNOSTICS).
The best stock recommendation documented was for TCMD (TACTILE SYSTEMS TECHNOLOGY) at 2/18/2026. The price target of $32 was fulfilled within 1 day with a profit of $1.05 (3.18%) receiving and performance score of 31.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Jul-2021
$7.5
5 years 2 months 29 days ago
(22-Jul-2021)
2/2 (100%)
$2.76 (58.23%)
256
Hold Since 03-Dec-2020
$10
$9.54 (2073.91%)
$8
5 years 10 months 18 days ago
(03-Dec-2020)
0/3 (0%)
$2.49 (33.16%)
Hold Since 17-Jun-2020
$7
6 years 4 months 4 days ago
(17-Jun-2020)
2/2 (100%)
$-0.16 (-2.23%)
151
Buy Since 26-May-2020
$4
$3.54 (769.57%)
$21
6 years 4 months 4 days ago
(17-Jun-2020)
1/2 (50%)
$0.11 (2.83%)
15
Buy Since 04-Jan-2019
$9
6 years 10 months 5 days ago
(16-Dec-2019)
2/2 (100%)
$4.61 (105.01%)
309
Which stock is Kyle Bauser most bullish on?
Which stock is Kyle Bauser most reserved on?
What Year was the first public recommendation made by Kyle Bauser?
